159 related articles for article (PubMed ID: 24289857)
1. Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Abdel Raheem A; Ralph D
Eur Urol; 2014 Jan; 65(1):251-2. PubMed ID: 24289857
[No Abstract] [Full Text] [Related]
2. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
[TBL] [Abstract][Full Text] [Related]
3. Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies: M. Gelbard, I. Goldstein, W. J. Hellstrom, C. G. McMahon, T. Smith, J. Tursi, N. Jones, G. J. Kaufman and C. C. Carson, III J Urol 2013; 190: 199-207.
Jain S; Mavuduru RM; Agarwal MM; Singh SK; Mandal AK
J Urol; 2014 Feb; 191(2):561-3. PubMed ID: 24239419
[No Abstract] [Full Text] [Related]
4. Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease.
Gelbard M; Lipshultz LI; Tursi J; Smith T; Kaufman G; Levine LA
J Urol; 2012 Jun; 187(6):2268-74. PubMed ID: 22503048
[TBL] [Abstract][Full Text] [Related]
5. Reply by authors.
J Urol; 2014 Feb; 191(2):562-3. PubMed ID: 24239418
[No Abstract] [Full Text] [Related]
6. [Peyronie's disease - drug treatment].
Plas E
Aktuelle Urol; 2014 Mar; 45(2):96-7. PubMed ID: 24700061
[No Abstract] [Full Text] [Related]
7. Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
Mills SA; Gelbard MK
World J Urol; 2020 Feb; 38(2):269-277. PubMed ID: 31168744
[TBL] [Abstract][Full Text] [Related]
8. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
9. Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies.
Kadioglu A; Boyuk A; Salabas E
Eur Urol; 2015 Nov; 68(5):908-9. PubMed ID: 26460876
[No Abstract] [Full Text] [Related]
10. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
11. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
Dhillon S
Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
[TBL] [Abstract][Full Text] [Related]
12. Managing complications of collagenase Clostridium histolyticum (CCH) injection.
Greear GM; Koprowski CJ; Hsieh TC
World J Urol; 2020 Feb; 38(2):287-292. PubMed ID: 31123850
[TBL] [Abstract][Full Text] [Related]
13. Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
Abdel Raheem A; Johnson M; Abdel-Raheem T; Capece M; Ralph D
Sex Med Rev; 2017 Oct; 5(4):529-535. PubMed ID: 28874327
[TBL] [Abstract][Full Text] [Related]
14. Re: Clinical Experience with Penile Traction Therapy among Men Undergoing Collagenase Clostridium Histolyticum for Peyronie Disease.
Morey AF
J Urol; 2018 Jan; 199(1):20-21. PubMed ID: 29310171
[No Abstract] [Full Text] [Related]
15. Re: Clinical Experience with Penile Traction Therapy among Men Undergoing Collagenase Clostridium histolyticum for Peyronie Disease.
Seftel AD
J Urol; 2017 Sep; 198(3):467-468. PubMed ID: 28817884
[No Abstract] [Full Text] [Related]
16. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
[TBL] [Abstract][Full Text] [Related]
17. A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease results in reduced procedural morbidity using a standardized hematoma classification rubric.
Amighi A; Mills SA; Eleswarapu SV; Regets KV; Mendhiratta N; Mills JN
World J Urol; 2020 Feb; 38(2):293-298. PubMed ID: 31152197
[TBL] [Abstract][Full Text] [Related]
18. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
19. Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease.
Hellstrom WJG; Tan RBW; Liu G
Urology; 2017 Aug; 106():237.e9-237.e14. PubMed ID: 28502596
[TBL] [Abstract][Full Text] [Related]
20. Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach.
Gelbard MK; Chagan L; Tursi JP
J Sex Med; 2015 Jun; 12(6):1481-9. PubMed ID: 25940867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
